Peter J. Schwartz, MD
Peter J. Schwartz is currently Professor and Chairman of Cardiology at the University of Pavia; Director of the School for the Board in Cardiology and Chairman of the Blood, Lung and Heart Department at the same university; Chief of the Coronary Care Unit at Policlinico, San Matteo, Pavia (Italy); Professor of Physiology and Biophysics at the University of Oklahoma (OK, USA); Extraordinary Professor in Internal Medicine at the University of Stellenbosch; and Honorary Professor of Internal Medicine at the University of Capetown, South Africa.
During the last 30 years he has investigated in detail the congenital long QT syndrome. After having contributed to the description of the clinical presentation and response to therapy, he has more recently provided novel insights in the genotype-phenotype correlation with special emphasis on gene-specific triggers for cardiac events and on gene-specific differential responses to a variety of therapeutic interventions. Currently, he and his research group are searching "modifier genes" with the potential of modifying the severity of the clinical manifestations of the long QT syndrome. Dr. Schwartz is the only European investigator who has been receiving uninterrupted funding for his research activity from the National Institutes of Health (NIH) of the USA since 1974.
Dr. Schwartz serves the leading cardiology journals as a member of the Editorial Board or as a reviewer. He is the author of 1173 publications: 12 books, 145 chapters, 355 original articles, and 661 abstracts. His impact factor in the last eight years is 876,656.
Return to Scientific Advisory Board
